Trajan and University of Adelaide's IPAS partnership video

Trajan and University of Adelaide's IPAS partnership video

November 01, 2016

Watch to find out how the strategic collaboration between Trajan Scientific and Medical (Trajan) and the University of Adelaide's Institute for Photonics and Advanced Sensing (IPAS) came into being.

The video features Trajan's CEO Mr Stephen Tomisich, and Dr Anne Collins, General Manager of Trajan's Instruments, Sensors and Devices business unit; outlining why IPAS was chosen as an ideal location for collaborating on specialty glass products for the global science and medical equipment market.

IPAS Deputy Director Prof Heike Ebendorff-Heidepriem, and IPAS Institute Manager, Mr Piers Lincoln, also discuss the benefits for universities working with a global commercial partner such as Trajan.

Sneak a peek into the state of the art facilities in the video below, and subscribe to Trajan's YouTube channel, and IPAS' YouTube channel.

Related news
2016 Science Excellence Awards SA
University’s partnership proves Agenda’s strengths
Trajan announces landmark collaboration in R&D and manufacturing with Australian academia and government

More information
The University of Adelaide

Media contact information
Trajan Scientific and Medical
media@trajanscimed.com
+44 (0) 1244 403 100




Also in News

Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst
Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst

September 07, 2020

Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.

Read More

European patent for Trajan’s hemaPEN
European patent for Trajan’s hemaPEN

July 13, 2020

Trajan Scientific and Medical is proud to advise that the European Patent Office will be granting a patent for hemaPEN® as a liquid collection device in Belgium, France, Germany, Ireland, Luxembourg, Monaco, Switzerland, Liechtenstein and the United Kingdom. Extensions are being sought across the remainder of Europe.

Read More

US FDA listing of Trajan’s hemaPEN blood microsampling device
US FDA listing of Trajan’s hemaPEN blood microsampling device

July 02, 2020

Trajan Scientific and Medical has listed its hemaPEN® blood microsampling device with the U.S. Food and Drug Administration as Class I for therapeutic and in vitro diagnostic use. This follows the hemaPEN’s recent registration in May for supply in the EU and UK as a General IVD; as well as inclusion in the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class I IVD.

Read More